phenylacetylglutamine has been researched along with Arrhythmias, Cardiac in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, H; Huang, H; Kong, B; Shuai, W; Zhu, J | 1 |
1 other study(ies) available for phenylacetylglutamine and Arrhythmias, Cardiac
| Article | Year |
|---|---|
Phenylacetylglutamine increases the susceptibility of ventricular arrhythmias in heart failure mice by exacerbated activation of the TLR4/AKT/mTOR signaling pathway.
Topics: Animals; Arrhythmias, Cardiac; Disease Models, Animal; Heart Failure; Mice; Proto-Oncogene Proteins c-akt; Signal Transduction; Toll-Like Receptor 4; TOR Serine-Threonine Kinases | 2023 |